As shown in Fig. 1B,C, three genes (ABCA12, B3GNT3, and BMF) and eight miRNA (hsa.miR.577, hsa.miR.503, hsa.miR.3613, hsa.miR.19a, hsa.miR.19b.2, hsa.miR.365a, hsa.miR.365b, and hsa.miR.4668) were found to be dysregulated in four different stages of pancreatic cancer. This evidence concerns the gene B3GNT3 and familial pancreatic carcinoma.